Gilead executive converts 2,223 stock units to shares

Q: How many GILD shares did Erin Burkhart receive and have withheld?

Erin Burkhart converted 2,223 restricted stock units into 2,223 common shares on September 22, 2026; 768 shares were delivered or withheld for payment of exercise price or tax liability at $152.67 per share.

Q: How do GILD restricted stock units vest?

The restricted stock units have a 4-year vesting schedule: 25% vest on the first anniversary of the grant date, and the balance vests 6.25% quarterly thereafter until fully vested.

The restricted stock units follow a 4-year schedule, with 25% vesting on the grant's first anniversary and the balance vesting quarterly.

Available on EDGAR 09/23/2026 - 04:17 PM EDT Accepted by SEC EDGAR 09/23/2026 - 04:17 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

At Gilead Sciences, Inc., SVP, Controllership Erin Burkhart converted 2,223 restricted stock units into 2,223 common shares on September 22, 2026. Another 768 shares were delivered or withheld for payment of exercise price or tax liability at $152.67 per share. Her reported post-transaction position included 9,022 restricted stock units. No Rule 10b5-1 plan is reported.

Insider Trade Summary

2,223 shares exercised/converted

Exercise 3 txns

Insider Burkhart Erin

Role SVP, Controllership

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit ^{F1, F2}	2,223	--	--
Exercise	Common Stock ^F1	2,223	--	--
Exercise Price or Tax Liability	Common Stock	768	$152.67	$117K

Holdings After Transaction: Restricted Stock Unit — 9,022 units (Direct); Common Stock — 1,455 shares (Direct)

Holdings Before and After: Restricted Stock Unit, 11,245 to 9,022 units (Direct); Common Stock, 0 to 1,455 shares (Direct)

Footnotes (2)

F1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Key Figures

Restricted stock units converted: 2,223 restricted stock units Common shares received: 2,223 common shares Shares delivered or withheld: 768 shares +5 more

8 metrics

Restricted stock units converted 2,223 restricted stock units September 22, 2026

Common shares received 2,223 common shares September 22, 2026

Shares delivered or withheld 768 shares For payment of exercise price or tax liability on September 22, 2026

Price per share $152.67 per share Shares delivered or withheld on September 22, 2026

Restricted stock units following transaction 9,022 restricted stock units Reported post-transaction position

Vesting schedule 4 years Restricted stock units

First-anniversary vesting 25% Vests on the first anniversary of the grant date

Subsequent vesting 6.25% quarterly Balance vests quarterly until fully vested

Key Terms

restricted stock unit, contingent right, vesting schedule

3 terms

restricted stock unit financial

"Each restricted stock unit represents the contingent right"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right financial

"contingent right to receive one share"

vesting schedule financial

"The restricted stock units have a 4-year vesting schedule"

A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GILD shares did Erin Burkhart receive and have withheld?

Erin Burkhart converted 2,223 restricted stock units into 2,223 common shares on September 22, 2026; 768 shares were delivered or withheld for payment of exercise price or tax liability at $152.67 per share.

How do GILD restricted stock units vest?

The restricted stock units have a 4-year vesting schedule: 25% vest on the first anniversary of the grant date, and the balance vests 6.25% quarterly thereafter until fully vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burkhart Erin

(Last)

(First)

(Middle)

333 LAKESIDE DRIVE

(Street)

FOSTER CITY

CALIFORNIA

94404

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Controllership

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/22/2026		M		2,223	A	⁽¹⁾	2,223	D
Common Stock	09/22/2026		F		768	D	$152.67	1,455	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	09/22/2026		M			2,223	⁽²⁾	⁽²⁾	Common Stock	2,223	⁽¹⁾	9,022	D

Explanation of Responses:

1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Remarks:

	/s/ Amy Kim by Power of Attorney for Erin E. Burkhart	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR